$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
尼拉帕尼治疗卵巢癌患者的疗效
2025-10-19 11:44:20
Check Details
PARP抑制剂尼拉帕尼治疗卵巢癌的疗效
2025-10-19 11:44:20
Check Details
奥拉帕尼用于卵巢癌患者术后的维持疗法
2025-10-19 11:44:20
Check Details
奥拉帕尼治疗铂敏感复发性浆液性卵巢癌患者
2025-10-19 11:44:20
Check Details
尼拉帕利延长存在BRCA 突变患者的生存期
2025-10-19 11:44:20
Check Details
尼拉帕尼治疗BRCA突变卵巢癌患者疗效显著
2025-10-19 11:44:20
Check Details
尼拉帕尼治疗卵巢癌优于安慰剂
2025-10-19 11:44:20
Check Details
奥拉帕尼治疗复发性卵巢癌时,效果如何?
2025-10-19 11:44:20
Check Details
卵巢癌患者PARP抑制剂尼拉帕尼
2025-10-19 11:44:20
Check Details
奥拉帕尼治疗存在BRCA突变的卵巢癌患者
2025-10-19 11:44:20
Check Details
铂类耐药的卵巢癌患者可服用索拉非尼进行治疗
2025-10-19 11:44:20
Check Details
尼拉帕尼( Niraparib )治疗复发性卵巢癌
2025-10-19 11:44:20
Check Details
1
2
...
765
766
767
768
769
770
771
...
4151
4152
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
2
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment
3
Comprehensive Analysis of the Third-Generation EGFR-TKI
4
ATOMIC Study: Atezolizumab Plus Chemo Improves DFS in dMMR Stage III Colon Cancer
5
Oncology Immunotherapy vs Anti-Inflammatory Biologic: Dostarlimab vs Secukinumab - A Mechanism-Centered Comparison
6
Third-Generation TKI Redefining Treatment for ALK+ & ROS1+ NSCLC
7
Brigatinib Medication Case Study: Three-Year Treatment Record and Experience Sharing of ALK-Positive Lung Cancer Patient
8
What is Brigatinib (Alunbrig)? Complete Guide to ALK-Positive Lung Cancer Targeted Therapy & Medication Guidelines
9
Repotrectinib (Augtyro) Complete Medication Guide 2026: Import Original Drug Price, Eligible Patients & Full Usage Information
10
Ceritinib Capsule Storage Conditions & Expiration Guide: Room Temperature Storage, No Refrigeration Needed
11
Selumetinib for NF1 Treatment: Complete Guide to Targeted Therapy for Type 1 Neurofibromatosis
12
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook